PI
LUCD icon

Putnam Investments’s Lucid Diagnostics LUCD Stock Holding History

Putnam Investments’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-241,972
Closed -$813K – 1174
2022
Q1 		$813K Hold
241,972
– – ﹤0.01% 918
2021
Q4 		$1.3M Buy
+241,972
New +$1.96M ﹤0.01% 834

Other funds holding LUCD

LM
Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
GWM
Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Putnam Investments's LUCD Position: Q2 2022 in Review

Putnam Investments sold out of Lucid Diagnostics (LUCD) in Q2 2022, closing a stake of 241,972 shares — an estimated $813K sold.

Putnam Investments first reported a position in LUCD in Q4 2021 and held it in 2 quarters. The position peaked at $1.3M in Q4 2021. 31 funds tracked by Wall St. Rank hold LUCD as of Q2 2022.

  • Putnam Investments reported no remaining Lucid Diagnostics position as of Q2 2022 after selling out during the quarter.
  • Putnam Investments sold 241,972 Lucid Diagnostics shares in Q2 2022, an estimated $813K.
  • Putnam Investments first reported a position in Lucid Diagnostics in Q4 2021 and held it in 2 quarters.
  • Putnam Investments's Lucid Diagnostics position peaked at $1.3M in Q4 2021.
  • 31 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2022.

Based on Putnam Investments's 13F filing for Q2 2022, filed 15 Aug 2022.